GSK's tuberculosis vaccine shows promising results

The new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya,
South Africa and Zambia in adults whose blood tests showed they had
latent TB. The study revealed that the vaccine could cut the number of
people developing TB by half.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gsks-tuberculosis-vaccine-shows-promising-results/articleshow/71803087.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 30.11.2021 CSIR-IGIB Rs 1.5 Lakh pm Pay Job, ACTREC High Pay

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission